782-C Regulatory T-cell tumor infiltration is associated to better outcome in advanced NSCLC patients under ≥2nd line anti-PD1/L1 monotherapy in the PIONeeR project

Lignende værker

• Efficacy and toxicity profile of first‐line treatment for extensive‐stage small cell lung cancer: A Bayesian network meta‐analysis
  af: Guo Lin, et al.
  Udgivet: (2023-05-01)
• Efficacy and safety of early radiotherapy combined with first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: a multi-center analysis
  af: Jingyi Jia, et al.
  Udgivet: (2026-01-01)
• Correction: Efficacy and safety of early radiotherapy combined with first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: a multi-center analysis
  af: Jingyi Jia, et al.
  Udgivet: (2026-03-01)
• The efficacy and safety of immunotherapy as first−line treatment for extensive-stage small cell lung cancer: evaluating based on reconstructed individual patient data
  af: Shuang Zhang, et al.
  Udgivet: (2024-07-01)
• Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
  af: Arani Sathiyapalan, et al.
  Udgivet: (2022-11-01)